How should tachycardia occurring during plasma donation be managed?

Management of Tachycardia During Plasma Donation

Immediately stop the plasma donation procedure and assess the donor for signs of serious transfusion-related reactions, volume depletion, or citrate toxicity, as tachycardia during apheresis procedures can signal life-threatening complications.

Initial Assessment and Immediate Actions

When tachycardia occurs during plasma donation, you must:

• Stop the donation immediately and disconnect the donor from the apheresis equipment
• Assess vital signs comprehensively: blood pressure, respiratory rate, temperature, and oxygen saturation
• Look specifically for signs of circulatory compromise or fluid overload, as tachycardia combined with hypertension may indicate transfusion-associated circulatory overload (TACO), which is now the most common cause of transfusion-related mortality 1
• Evaluate for respiratory symptoms (dyspnea, tachypnea) which are typical early symptoms of serious transfusion reactions 1

Differential Diagnosis During Plasma Donation

The tachycardia may represent several distinct pathophysiologic processes:

Volume-Related Issues

• Hypovolemia from plasma removal: Apheresis donors have up to 6.5 L of blood processed, creating significant intravascular volume shifts 2
• Monitor for hypotension (occurred in 2.6% of plasma exchanges in one series) 3

Citrate Toxicity

• Citrate anticoagulant used during apheresis can cause toxic reactions (7.8% incidence) and affect cardiac contractility through reduction in ionized calcium 2, 3
• Symptoms may include perioral tingling, paresthesias, muscle cramping, and cardiac arrhythmias
• Cardiac arrhythmia is a documented serious complication of plasma exchange 3

Cardiac Abnormalities

• Pre-existing unrecognized cardiac disease may be unmasked during the procedure
• Donors with cardiac abnormalities are at increased risk of severe adverse reactions from repeated volume loss or citrate effects 2

Management Algorithm

Step 1: Stabilize the Donor

• Place donor in Trendelenburg or supine position with legs elevated
• Ensure IV access is maintained
• Administer normal saline bolus if hypotensive
• Monitor continuously

Step 2: Assess for Specific Complications

• If tachycardia + hypertension + respiratory symptoms: Suspect TACO

  • Slow or stop any fluid administration
  • Consider diuretics if fluid overload evident
  • Obtain chest imaging if respiratory compromise present

• If tachycardia + hypotension: Suspect hypovolemic reaction

  • Administer IV fluids aggressively
  • Keep donor supine until hemodynamically stable

• If symptoms of citrate toxicity (tingling, cramping):

  • Administer oral or IV calcium supplementation
  • Slow the return rate if procedure must continue

Step 3: Cardiac Evaluation

• Obtain 12-lead ECG to rule out arrhythmia or ischemia
• Any donor with persistent tachycardia (>100 bpm) or irregular pulse should be deferred from future donations and referred to their primary care physician 2
• In the study of 3,945 apheresis donors, 238 (6%) had abnormal pulses requiring referral, and 15 (0.4%) were found to have significant cardiac disease 2

Common Pitfalls to Avoid

• Do not resume the donation procedure until the cause of tachycardia is identified and resolved
• Do not assume tachycardia is benign anxiety: Cardiac arrhythmia and myocardial infarction have been documented during plasma exchange 3
• Do not use medications indiscriminately: Avoid routine premedication with antihistamines or steroids unless specific allergic reaction is identified 1
• Do not allow bradycardic donors (pulse <50 bpm) to donate without physician approval, though evidence suggests they are as safe as normocardic donors when properly screened 4

Disposition and Follow-Up

• Defer the donor from completing this donation session
• Monitor vital signs every 15 minutes until stable and normalized
• Do not allow donor to leave until heart rate is <100 bpm and stable for at least 30 minutes
• Mandatory referral to primary care physician for any persistent tachycardia or abnormal rhythm 2
• Document the reaction thoroughly for future donation screening
• Consider permanent deferral if significant cardiac disease is identified

Prevention for Future Donations

For donors who experienced tachycardia but are cleared for future donations:

• Pre-donation pulse assessment is essential for all apheresis donors 2
• Acceptable pulse range is 50-100 bpm 2, 4
• Ensure adequate hydration before donation
• Consider slower collection rates
• Monitor vital signs at baseline, 15 minutes after start, and within 60 minutes of completion 1

The medicolegal duty requires not putting donors at avoidable risk 2, so err on the side of caution with any cardiovascular instability during plasma donation.